期刊
HUMAN GENE THERAPY
卷 13, 期 5, 页码 605-612出版社
MARY ANN LIEBERT INC PUBL
DOI: 10.1089/10430340252837206
关键词
-
资金
- NIA NIH HHS [P01 AG10485] Funding Source: Medline
- NATIONAL INSTITUTE ON AGING [P01AG010485] Funding Source: NIH RePORTER
Somatic cell gene transfer was used to express a mutant form of alpha-synuclein (alpha-syn) that is associated with Parkinson's disease (PD) in the rat substantia nigra (SN), a brain region that, in humans, degenerates during PD. DNA encoding the A30P mutant of human alpha-syn linked to familial PD was incorporated into an adeno- associated virus vector, which was injected into the adult rat midbrain. The cytomegalovirus/ chicken beta- actin promoter was used to drive transgene expression. Over a 1- year time course, this treatment produced three significant features relevant to PD: (1) accumulation of alpha- syn in SN neuron perikarya, (2) Lewy- like dystrophic neurites in the SN and the striatum, and (3) a 53% loss of SN dopamine neurons. However, motor dysfunction was not found in either rotational or rotating rod testing. The lack of behavioral deficits, despite the significant cell loss, may reflect pathogenesis similar to that of PD, where greater than 50% losses occur before motor behavior is affected.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据